Peter Ellingworth
Chief Executive
Biography
Peter is Chief Executive of the Association of British HealthTech Industries (ABHI), the UK’s leading HealthTech Trade Association, with 400 members operating across medical devices, diagnostics and digital health. Working at both national and regional levels with senior government and the NHS, ABHI is focused on ensuring that policies and practices support the growth of our members and industry, thus enabling access to effective and life-changing technologies for patients.
Peter represents the industry on several formal government bodies and committees. He is a member of the Secretary of State-led Life Sciences Council and served as the leading voice for the sector on the Advisory Group for the Innovation System Programme, overseen by Roland Sinker on behalf of NHS England. In 2025, he was appointed to the MHRA’s National Commission on the Regulation of AI in Healthcare, where he sits on the Commission’s Technology Working Group. He is also a member of the Board of the Office for Strategic Coordination of Health Research (OSCHR), where he is focused on building strong and productive links between the HealthTech industry and the wider science and research community. He previously served on the Board of the Accelerated Access Collaborative and was an advisor to the Department of Health and Social Care’s MedTech Strategy Programme Board.
At a regional level, Peter has a long history of involvement, beginning with the inception of the Academic Health Science Networks and continuing through their evolution into Health Innovation Networks. He has held Board-level roles with Manchester and South London, and since 2018, he has served as a Board Director at Oxford & Thames Valley, where his leadership culminated in his appointment as Chair in 2024. Additionally, Peter leads ABHI’s partnership agreement with the Shelford Group, a collaboration of ten major research and teaching hospitals in England, designed to strengthen NHS-industry relationships and accelerate research and innovation.
He is a Board Member of MedTech Europe and Chairs its UK Working Group, which focuses on developing support for the harmonisation of critical policy matters for our industry, such as regulation, sustainability, and data. He also leads ABHI’s engagement with AdvaMed, through a joint memorandum of understanding, and the Global Medical Technology Alliance.
Peter has an extensive background in business with international companies in the UK and Europe and holds non-executive roles with early stage HealthTech companies. He is a committed champion for ABHI's important work on women’s health.
